Jim,Financial advisors often coach clients to diversify their portfolios, recommending they assign a certain percentage of assets to international or global funds to hedge against potential U.S. market declines. That’s the message delivered in an article from Reuters. It quotes IMS Health as seeing 12% to 14% pharmaceutical growth next near in Brazil, China, India, Mexico, Russia, South Korea, and Turkey. Emerging market growth is also predicted in the “2010 Forecast” to be published in the December issues of Healthcare Packaging and Packaging World magazines. The Reuters article reveals growth in emerging markets for companies including Pfizer, Novartis, GlaxoSmithKline Plc, Sanofi-Aventis, Novo Nordisk, and AstraZeneca Plc. Keep in mind that it’s important to develop a strategic approach to emerging markets, as long-term investments may be necessary to gain a satisfactory return on investment.
Global investment could yield a handsome return
Emerging markets could offset declining domestic income for U.S. pharmaceutical firms.
Nov 12, 2009
Recommended
Recommended
Recommended
Machinery Basics
Conveying Innovations Report
Editors report on distinguishing characteristics that define each new product and collected video demonstrating the equipment or materials as displayed at the show. This topical report, winnowed from nearly 300 PACK EXPO collective booth visits, represents a categorized, organized account of individual items that were selected based on whether they were deemed to be both new, and truly innovative, based on decades of combined editorial experience in experiencing and evaluating PACK EXPO products.
Take me there
2024 PACK EXPO Innovations Reports
Exclusive access: Packaging World editor-curated reports revealing PACK EXPO's most groundbreaking technologies across food, healthcare, and machinery sectors. Each report features truly innovative solutions selected from hundreds of exhibitors by our expert team. Transform your operations with just one click.
Access Now
